{"count":220314,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=854","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=852","results":[{"created":"2022-05-05T20:13:42.313494+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13839","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CYP7B1 as ready","entity_name":"CYP7B1","entity_type":"gene"},{"created":"2022-05-05T20:13:42.302376+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13839","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cyp7b1 has been classified as Green List (High Evidence).","entity_name":"CYP7B1","entity_type":"gene"},{"created":"2022-05-05T20:13:18.416022+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13839","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CYP7B1 were changed from  to Bile acid synthesis defect, congenital, 3 MIM#613812; Spastic paraplegia 5A, autosomal recessive MIM#270800; Disorders of bile acid biosynthesis","entity_name":"CYP7B1","entity_type":"gene"},{"created":"2022-05-05T20:12:48.338832+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13838","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYP7B1 were set to ","entity_name":"CYP7B1","entity_type":"gene"},{"created":"2022-05-05T20:12:26.853864+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13837","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CYP7B1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP7B1","entity_type":"gene"},{"created":"2022-05-05T20:09:52.670101+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13836","user_name":"Ain Roesley","item_type":"entity","text":"Marked gene: CYP1A2 as ready","entity_name":"CYP1A2","entity_type":"gene"},{"created":"2022-05-05T20:09:52.658811+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13836","user_name":"Ain Roesley","item_type":"entity","text":"Gene: cyp1a2 has been classified as Red List (Low Evidence).","entity_name":"CYP1A2","entity_type":"gene"},{"created":"2022-05-05T20:09:44.234429+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13836","user_name":"Ain Roesley","item_type":"entity","text":"Classified gene: CYP1A2 as Red List (low evidence)","entity_name":"CYP1A2","entity_type":"gene"},{"created":"2022-05-05T20:09:44.223014+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13836","user_name":"Ain Roesley","item_type":"entity","text":"Gene: cyp1a2 has been classified as Red List (Low Evidence).","entity_name":"CYP1A2","entity_type":"gene"},{"created":"2022-05-05T20:09:28.695234+10:00","panel_name":"Palmoplantar Keratoderma and Erythrokeratoderma","panel_id":153,"panel_version":"0.120","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: KLF4 was changed from MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"KLF4","entity_type":"gene"},{"created":"2022-05-05T20:09:26.688370+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13835","user_name":"Ain Roesley","item_type":"entity","text":"reviewed gene: CYP1A2: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None; Current diagnostic: yes","entity_name":"CYP1A2","entity_type":"gene"},{"created":"2022-05-05T20:08:42.607180+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13835","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: KLF4 as ready","entity_name":"KLF4","entity_type":"gene"},{"created":"2022-05-05T20:08:42.596196+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13835","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: klf4 has been classified as Green List (High Evidence).","entity_name":"KLF4","entity_type":"gene"},{"created":"2022-05-05T20:08:30.059754+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13835","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: KLF4 was changed from MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"KLF4","entity_type":"gene"},{"created":"2022-05-05T20:07:48.273241+10:00","panel_name":"Leukodystrophy - paediatric","panel_id":298,"panel_version":"0.264","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NDUFV2 as ready","entity_name":"NDUFV2","entity_type":"gene"},{"created":"2022-05-05T20:07:48.261473+10:00","panel_name":"Leukodystrophy - paediatric","panel_id":298,"panel_version":"0.264","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ndufv2 has been classified as Green List (High Evidence).","entity_name":"NDUFV2","entity_type":"gene"},{"created":"2022-05-05T20:07:38.379933+10:00","panel_name":"Leukodystrophy - paediatric","panel_id":298,"panel_version":"0.264","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NDUFV2 as Green List (high evidence)","entity_name":"NDUFV2","entity_type":"gene"},{"created":"2022-05-05T20:07:38.368709+10:00","panel_name":"Leukodystrophy - paediatric","panel_id":298,"panel_version":"0.264","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ndufv2 has been classified as Green List (High Evidence).","entity_name":"NDUFV2","entity_type":"gene"},{"created":"2022-05-05T20:07:27.327865+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13834","user_name":"Ain Roesley","item_type":"entity","text":"Marked gene: CYP19A1 as ready","entity_name":"CYP19A1","entity_type":"gene"},{"created":"2022-05-05T20:07:27.317279+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13834","user_name":"Ain Roesley","item_type":"entity","text":"Gene: cyp19a1 has been classified as Green List (High Evidence).","entity_name":"CYP19A1","entity_type":"gene"},{"created":"2022-05-05T20:07:17.488574+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13834","user_name":"Ain Roesley","item_type":"entity","text":"Tag SV/CNV tag was added to gene: CYP19A1.","entity_name":"CYP19A1","entity_type":"gene"},{"created":"2022-05-05T20:07:16.456170+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13834","user_name":"Ain Roesley","item_type":"entity","text":"Phenotypes for gene: CYP19A1 were changed from  to Aromatase deficiency (MIM#613546), AR; Aromatase excess syndrome (MIM#139300), AD","entity_name":"CYP19A1","entity_type":"gene"},{"created":"2022-05-05T20:07:09.697090+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13833","user_name":"Ain Roesley","item_type":"entity","text":"Publications for gene: CYP19A1 were set to ","entity_name":"CYP19A1","entity_type":"gene"},{"created":"2022-05-05T20:07:05.449143+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13833","user_name":"Ain Roesley","item_type":"entity","text":"Mode of inheritance for gene: CYP19A1 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"CYP19A1","entity_type":"gene"},{"created":"2022-05-05T20:06:55.959715+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.194","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: P3H2 as ready","entity_name":"P3H2","entity_type":"gene"},{"created":"2022-05-05T20:06:55.948037+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.194","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: p3h2 has been classified as Green List (High Evidence).","entity_name":"P3H2","entity_type":"gene"},{"created":"2022-05-05T20:06:49.598181+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.194","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: P3H2 as Green List (high evidence)","entity_name":"P3H2","entity_type":"gene"},{"created":"2022-05-05T20:06:49.587454+10:00","panel_name":"Proteinuria","panel_id":144,"panel_version":"0.194","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: p3h2 has been classified as Green List (High Evidence).","entity_name":"P3H2","entity_type":"gene"},{"created":"2022-05-05T20:06:44.545163+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13832","user_name":"Ain Roesley","item_type":"entity","text":"reviewed gene: CYP19A1: Rating: GREEN; Mode of pathogenicity: None; Publications: 17164303, 25264451; Phenotypes: Aromatase deficiency (MIM#613546), AR, Aromatase excess syndrome (MIM#139300), AD; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal; Current diagnostic: yes","entity_name":"CYP19A1","entity_type":"gene"},{"created":"2022-05-05T20:04:27.859835+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13832","user_name":"Ain Roesley","item_type":"entity","text":"Marked gene: CYCS as ready","entity_name":"CYCS","entity_type":"gene"},{"created":"2022-05-05T20:04:27.849795+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13832","user_name":"Ain Roesley","item_type":"entity","text":"Gene: cycs has been classified as Green List (High Evidence).","entity_name":"CYCS","entity_type":"gene"},{"created":"2022-05-05T20:04:15.083847+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13832","user_name":"Ain Roesley","item_type":"entity","text":"Phenotypes for gene: CYCS were changed from  to Thrombocytopenia 4, MIM# 612004","entity_name":"CYCS","entity_type":"gene"},{"created":"2022-05-05T20:04:11.049618+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13831","user_name":"Ain Roesley","item_type":"entity","text":"Publications for gene: CYCS were set to ","entity_name":"CYCS","entity_type":"gene"},{"created":"2022-05-05T20:04:05.132226+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13831","user_name":"Ain Roesley","item_type":"entity","text":"Mode of inheritance for gene: CYCS was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CYCS","entity_type":"gene"},{"created":"2022-05-05T20:03:36.288762+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13830","user_name":"Ain Roesley","item_type":"entity","text":"reviewed gene: CYCS: Rating: GREEN; Mode of pathogenicity: None; Publications: 24326104, 18345000, 30051457; Phenotypes: Thrombocytopenia 4, MIM# 612004; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted; Current diagnostic: yes","entity_name":"CYCS","entity_type":"gene"},{"created":"2022-05-05T20:03:35.271781+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4751","user_name":"Ain Roesley","item_type":"entity","text":"Phenotypes for gene: CYC1 were changed from Mitochondrial complex III deficiency, nuclear type 6 MIM#615453 to Mitochondrial complex III deficiency, nuclear type 6 MIM#615453","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T20:03:17.188695+10:00","panel_name":"Renal Ciliopathies and Nephronophthisis","panel_id":193,"panel_version":"1.9","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TULP3 as ready","entity_name":"TULP3","entity_type":"gene"},{"created":"2022-05-05T20:03:17.175756+10:00","panel_name":"Renal Ciliopathies and Nephronophthisis","panel_id":193,"panel_version":"1.9","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tulp3 has been classified as Green List (High Evidence).","entity_name":"TULP3","entity_type":"gene"},{"created":"2022-05-05T20:03:13.531982+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4749","user_name":"Ain Roesley","item_type":"entity","text":"Phenotypes for gene: CYC1 were changed from Mitochondrial complex III deficiency, nuclear type 6 MIM#615453 to Mitochondrial complex III deficiency, nuclear type 6 MIM#615453","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T20:02:50.805562+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4750","user_name":"Ain Roesley","item_type":"entity","text":"Mode of inheritance for gene: CYC1 was changed from BIALLELIC, autosomal or pseudoautosomal to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T20:02:40.282432+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4750","user_name":"Ain Roesley","item_type":"entity","text":"Marked gene: CYC1 as ready","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T20:02:40.243668+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4750","user_name":"Ain Roesley","item_type":"entity","text":"Gene: cyc1 has been classified as Red List (Low Evidence).","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T20:02:21.614543+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13830","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NRG1 were changed from Hirschsprung disease to Hirschsprung disease, MONDO:0018309; Peripheral neuropathy MONDO:0005244","entity_name":"NRG1","entity_type":"gene"},{"created":"2022-05-05T20:02:18.988837+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4750","user_name":"Ain Roesley","item_type":"entity","text":"Phenotypes for gene: CYC1 were changed from  to Mitochondrial complex III deficiency, nuclear type 6 MIM#615453","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T20:01:58.654916+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4750","user_name":"Ain Roesley","item_type":"entity","text":"Publications for gene: CYC1 were set to 23910460; 34252606","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T20:01:34.291904+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4749","user_name":"Ain Roesley","item_type":"entity","text":"Publications for gene: CYC1 were set to ","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T20:01:03.530904+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4749","user_name":"Ain Roesley","item_type":"entity","text":"Mode of inheritance for gene: CYC1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T20:00:59.197499+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13829","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NRG1 as Amber List (moderate evidence)","entity_name":"NRG1","entity_type":"gene"},{"created":"2022-05-05T20:00:59.186347+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13829","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nrg1 has been classified as Amber List (Moderate Evidence).","entity_name":"NRG1","entity_type":"gene"},{"created":"2022-05-05T20:00:40.821779+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4749","user_name":"Ain Roesley","item_type":"entity","text":"Classified gene: CYC1 as Red List (low evidence)","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T20:00:40.804723+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4749","user_name":"Ain Roesley","item_type":"entity","text":"Gene: cyc1 has been classified as Red List (Low Evidence).","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T19:59:51.689846+10:00","panel_name":"Congenital Disorders of Glycosylation","panel_id":68,"panel_version":"1.28","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TRAPPC9: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Intellectual developmental disorder, autosomal recessive 13, MIM# 613192; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"TRAPPC9","entity_type":"gene"},{"created":"2022-05-05T19:59:50.845130+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4748","user_name":"Ain Roesley","item_type":"entity","text":"reviewed gene: CYC1: Rating: RED; Mode of pathogenicity: None; Publications: 23910460, 34252606; Phenotypes: Mitochondrial complex III deficiency, nuclear type 6 MIM#615453; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal; Current diagnostic: yes","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T19:57:44.910735+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13828","user_name":"Ain Roesley","item_type":"entity","text":"Marked gene: CYC1 as ready","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T19:57:44.888623+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13828","user_name":"Ain Roesley","item_type":"entity","text":"Gene: cyc1 has been classified as Green List (High Evidence).","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T19:57:15.391197+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13828","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CTR9 were changed from Neurodevelopmental disorder (MONDO:0700092), CTR9 related; Intellectual disability (MONDO:0001071); hypotonia (HP:0001252); joint hyperlaxity (HP:0001388); speech delay; coordination problems; tremor (HP:0001337); autism spectrum disorder (MONDO:0005258) to Neurodevelopmental disorder (MONDO:0700092), CTR9 related","entity_name":"CTR9","entity_type":"gene"},{"created":"2022-05-05T19:57:03.420571+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13827","user_name":"Ain Roesley","item_type":"entity","text":"Publications for gene: CYC1 were set to ","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T19:57:02.990325+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13828","user_name":"Ain Roesley","item_type":"entity","text":"Phenotypes for gene: CYC1 were changed from  to Mitochondrial complex III deficiency, nuclear type 6 MIM#615453","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T19:56:52.472888+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13827","user_name":"Ain Roesley","item_type":"entity","text":"Mode of inheritance for gene: CYC1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T19:56:36.829055+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4748","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CTR9 as ready","entity_name":"CTR9","entity_type":"gene"},{"created":"2022-05-05T19:56:36.817157+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4748","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ctr9 has been classified as Green List (High Evidence).","entity_name":"CTR9","entity_type":"gene"},{"created":"2022-05-05T19:56:11.535814+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13826","user_name":"Ain Roesley","item_type":"entity","text":"reviewed gene: CYC1: Rating: GREEN; Mode of pathogenicity: None; Publications: 23910460, 34252606; Phenotypes: Mitochondrial complex III deficiency, nuclear type 6 MIM#615453; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal; Current diagnostic: yes","entity_name":"CYC1","entity_type":"gene"},{"created":"2022-05-05T19:56:11.183660+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4748","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CTR9 were changed from Neurodevelopmental disorder (MONDO:0700092), CTR9-related; Intellectual disability (MONDO:0001071); hypotonia (HP:0001252); joint hyperlaxity (HP:0001388); speech delay; coordination problems; tremor (HP:0001337); autism spectrum disorder (MONDO:0005258) to Neurodevelopmental disorder (MONDO:0700092), CTR9-related","entity_name":"CTR9","entity_type":"gene"},{"created":"2022-05-05T19:55:31.584828+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4747","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CTR9 as Green List (high evidence)","entity_name":"CTR9","entity_type":"gene"},{"created":"2022-05-05T19:55:31.575311+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4747","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ctr9 has been classified as Green List (High Evidence).","entity_name":"CTR9","entity_type":"gene"},{"created":"2022-05-05T19:53:17.945926+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4746","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DNAH14 as Green List (high evidence)","entity_name":"DNAH14","entity_type":"gene"},{"created":"2022-05-05T19:53:17.936866+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4746","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dnah14 has been classified as Green List (High Evidence).","entity_name":"DNAH14","entity_type":"gene"},{"created":"2022-05-05T19:52:41.830995+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4745","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DNAH14 were changed from Neurodevelopmental disorder, DNAH14-related (MONDO#0700092) to Neurodevelopmental disorder (MONDO#0700092), DNAH14-related","entity_name":"DNAH14","entity_type":"gene"},{"created":"2022-05-05T19:52:40.737511+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4744","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DNAH14 as ready","entity_name":"DNAH14","entity_type":"gene"},{"created":"2022-05-05T19:52:40.722691+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4744","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dnah14 has been removed from the panel.","entity_name":"DNAH14","entity_type":"gene"},{"created":"2022-05-05T19:52:27.743955+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13826","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DNAH14 were changed from Neurodevelopmental disorder, DNAH14-related (MONDO#0700092) to Neurodevelopmental disorder (MONDO#0700092), DNAH14-related","entity_name":"DNAH14","entity_type":"gene"},{"created":"2022-05-05T19:51:30.497258+10:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1591","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DNAH14 as ready","entity_name":"DNAH14","entity_type":"gene"},{"created":"2022-05-05T19:51:30.484232+10:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1591","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dnah14 has been classified as Green List (High Evidence).","entity_name":"DNAH14","entity_type":"gene"},{"created":"2022-05-05T19:51:22.305042+10:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1591","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DNAH14 were changed from Neurodevelopmental disorder, DNAH14-related (MONDO#0700092) to Neurodevelopmental disorder (MONDO#0700092), DNAH14-related","entity_name":"DNAH14","entity_type":"gene"},{"created":"2022-05-05T19:50:10.353494+10:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1590","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DNAH14 as Green List (high evidence)","entity_name":"DNAH14","entity_type":"gene"},{"created":"2022-05-05T19:50:10.343498+10:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1590","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dnah14 has been classified as Green List (High Evidence).","entity_name":"DNAH14","entity_type":"gene"},{"created":"2022-05-05T19:48:32.605777+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13825","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HNRNPA2B1 were changed from Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2 MIM#615422 to oculopharyngeal muscular dystrophy, MONDO:0008116; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2 MIM#615422","entity_name":"HNRNPA2B1","entity_type":"gene"},{"created":"2022-05-05T19:47:58.078707+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13824","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: HNRNPA2B1 as Green List (high evidence)","entity_name":"HNRNPA2B1","entity_type":"gene"},{"created":"2022-05-05T19:47:58.065049+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13824","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hnrnpa2b1 has been classified as Green List (High Evidence).","entity_name":"HNRNPA2B1","entity_type":"gene"},{"created":"2022-05-05T19:47:32.269298+10:00","panel_name":"Congenital ophthalmoplegia","panel_id":3379,"panel_version":"1.5","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HNRNPA2B1 as ready","entity_name":"HNRNPA2B1","entity_type":"gene"},{"created":"2022-05-05T19:47:32.257839+10:00","panel_name":"Congenital ophthalmoplegia","panel_id":3379,"panel_version":"1.5","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hnrnpa2b1 has been classified as Green List (High Evidence).","entity_name":"HNRNPA2B1","entity_type":"gene"},{"created":"2022-05-05T19:47:25.583800+10:00","panel_name":"Congenital ophthalmoplegia","panel_id":3379,"panel_version":"1.5","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: HNRNPA2B1 as Green List (high evidence)","entity_name":"HNRNPA2B1","entity_type":"gene"},{"created":"2022-05-05T19:47:25.574517+10:00","panel_name":"Congenital ophthalmoplegia","panel_id":3379,"panel_version":"1.5","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hnrnpa2b1 has been classified as Green List (High Evidence).","entity_name":"HNRNPA2B1","entity_type":"gene"},{"created":"2022-05-05T19:03:53.287035+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"1.122","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DTYMK as ready","entity_name":"DTYMK","entity_type":"gene"},{"created":"2022-05-05T19:03:53.274619+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"1.122","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dtymk has been classified as Green List (High Evidence).","entity_name":"DTYMK","entity_type":"gene"},{"created":"2022-05-05T19:03:41.042542+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"1.122","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DTYMK as Green List (high evidence)","entity_name":"DTYMK","entity_type":"gene"},{"created":"2022-05-05T19:03:41.030951+10:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"1.122","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dtymk has been classified as Green List (High Evidence).","entity_name":"DTYMK","entity_type":"gene"},{"created":"2022-05-05T19:02:19.006752+10:00","panel_name":"Regression","panel_id":206,"panel_version":"0.473","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DTYMK as ready","entity_name":"DTYMK","entity_type":"gene"},{"created":"2022-05-05T19:02:18.995104+10:00","panel_name":"Regression","panel_id":206,"panel_version":"0.473","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dtymk has been classified as Green List (High Evidence).","entity_name":"DTYMK","entity_type":"gene"},{"created":"2022-05-05T19:02:13.280659+10:00","panel_name":"Regression","panel_id":206,"panel_version":"0.473","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DTYMK as Green List (high evidence)","entity_name":"DTYMK","entity_type":"gene"},{"created":"2022-05-05T19:02:13.271743+10:00","panel_name":"Regression","panel_id":206,"panel_version":"0.473","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dtymk has been classified as Green List (High Evidence).","entity_name":"DTYMK","entity_type":"gene"},{"created":"2022-05-05T19:01:43.220610+10:00","panel_name":"Regression","panel_id":206,"panel_version":"0.472","user_name":"Zornitza Stark","item_type":"entity","text":"gene: DTYMK was added\ngene: DTYMK was added to Regression. Sources: Expert Review\nMode of inheritance for gene: DTYMK was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: DTYMK were set to 34918187; 31271740\nPhenotypes for gene: DTYMK were set to Neurodegeneration, childhood-onset, with progressive microcephaly (MIM# 619847)\nReview for gene: DTYMK was set to GREEN\nAdded comment: Progressive neurodegenerative disorder, 3 families reported. \nSources: Expert Review","entity_name":"DTYMK","entity_type":"gene"},{"created":"2022-05-05T19:00:11.743783+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13823","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DTYMK were changed from Intellectual disability; microcephaly to Neurodegeneration, childhood-onset, with progressive microcephaly (MIM# 619847)","entity_name":"DTYMK","entity_type":"gene"},{"created":"2022-05-05T18:59:23.983707+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13822","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: DTYMK were set to 31271740","entity_name":"DTYMK","entity_type":"gene"},{"created":"2022-05-05T18:59:01.877539+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13821","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DTYMK as Green List (high evidence)","entity_name":"DTYMK","entity_type":"gene"},{"created":"2022-05-05T18:59:01.863290+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.13821","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dtymk has been classified as Green List (High Evidence).","entity_name":"DTYMK","entity_type":"gene"},{"created":"2022-05-05T18:58:07.837281+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4744","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PRDM13 were changed from intellectual disability, MONDO:0001071, PRDM13-associated; ataxia with cerebellar hypoplasia, MONDO:0016054, PRDM13-associated; congenital hypogonadotropic hypogonadism, MONDO:0015770 to intellectual disability, MONDO:0001071, PRDM13-associated; Pontocerebellar hypoplasia (MONDO:0020135), PRDM13 related; congenital hypogonadotropic hypogonadism, MONDO:0015770","entity_name":"PRDM13","entity_type":"gene"},{"created":"2022-05-05T18:57:34.514909+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4743","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: PRDM13 were set to 34730112","entity_name":"PRDM13","entity_type":"gene"},{"created":"2022-05-05T18:56:58.739744+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4742","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: PRDM13 as Green List (high evidence)","entity_name":"PRDM13","entity_type":"gene"},{"created":"2022-05-05T18:56:58.728000+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4742","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: prdm13 has been classified as Green List (High Evidence).","entity_name":"PRDM13","entity_type":"gene"}]}